Brunei Darussalam vs Indonesia: Hepatitis B surface antigen (HBsAg) prevalence
Brunei Darussalam
0.7%
in 2024
Indonesia
0.7%
in 2024
Brunei Darussalam rank
43rd
Indonesia rank
43rd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Brunei Darussalam
- Indonesia
How they compare
Brunei Darussalam currently reports 0.7% against 0.7% in Indonesia, a difference of 0.0%.
Across all 10 years both countries report, Indonesia has been ahead every year.
Brunei Darussalam ranks 43rd and Indonesia ranks 43rd of 194 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.9% | 0.9% | 0.0% | Indonesia |
| 2020s | 0.8% | 0.8% | 0.1% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Brunei Darussalam or Indonesia?
- Brunei Darussalam, at 0.7% against 0.7% in Indonesia as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Brunei Darussalam and Indonesia?
- 0.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and Indonesia?
- 10 years are reported by both, from 2015 to 2024.
- How do Brunei Darussalam and Indonesia rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Brunei Darussalam ranks 43rd and Indonesia ranks 43rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.